Facts About Paniculoside I Revealed
All enrolled individuals who gained no less than 1 dose of zosuquidar or placebo all through induction had been monitored to the incidence of adverse events (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse gatherings were being associated with the period of prolonged and considerable myelosuppression as is predicted